Evidence that decision-support tools can enhance diagnostic accuracy, reduce time-to-treatment in real-world settings and marks a significant step toward clinically implementable AI assistance in psychiatric diagnosis.
Raballo et al. 2025 https://t.co/Cvq6pC7Vvk
There is more than genetics and immediate social network in the intergenerational transmission of the vulnerability or resilience to mental disorders.
A new contribution by Raballo, Poletti, and Preti on the European Child & Adolescent Psychiatry
https://t.co/M5S2hXvRNA
1/ The “evidence-based therapy” game—explained with 🥞
I have a pancake recipe. I do randomized controlled trials (RCTs) showing that people like my 🥞 better than getting no breakfast at all
My🥞are now “evidence-based” & yours aren’t. I start telling everyone my🥞are superior
1/ It’s more helpful to think of depression as an effect, not cause. We can think of depression as the psychic equivalent of fever. Fever is a “nonspecific” symptom of a wide range of underlying conditions, from the common cold to ebola. Likewise, depression is a nonspecific
In individuals at clinical high risk for psychosis (CHR-P) who were exposed to antipsychotics at baseline, those receiving higher antipsychotic doses demonstrated an increased likelihood of transitioning to psychosis.
https://t.co/vjcxEdk80X
Exposure to antipsychotics modifies prognosis in Clinical High Risk for Psychosis.
Now, the newly launched ProNET (Psychosis Risk Outcomes Network, a project of the Accelerating Medicines Partnership for Schizophrenia) will consider it an exclusion criterion for enrollment.
The temporal dynamics of transition to psychosis in individuals at clinical high-risk (CHR-P) shows negative prognostic effects of baseline antipsychotic exposure: a meta-analysis | Translational Psychiatry @AntoViral
https://t.co/FHNsQLZHqF
The temporal dynamics of transition to psychosis in individuals at clinical high-risk (CHR-P) shows negative prognostic effects of baseline antipsychotic exposure: a meta-analysis | Translational Psychiatry https://t.co/hrho34MHWj
Does baseline exposure to antipsychotic medications influence brain morphometry in Clinical High Risk for Psychosis (CHR-P) individuals?
https://t.co/2fSXo5Bo7N